"Designing Growth Strategies is in our DNA"

Safety Pen Needles Market Size, Share & Industry Analysis, By Product Type (Active Safety Pen Needles and Passive Safety Pen Needles), By Drug Type (Insulin, GLP-1, Growth Hormone, and Others), By Disease Indication (Diabetes, Obesity, Hormone Deficiency, and Others), By Needle Size (4 mm, 5 mm, 6 mm, 8 mm, and 12 mm), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI113841

 


To get information on various segments, share your queries with us

 

ATTRIBUTE

DETAILS

Study Period

2021-2034

Base Year

2025

Forecast Period

2026-2034

Historical Period

2021-2024

Growth Rate

CAGR of 7.81% from 2026-2034

Unit

Value (USD Million)

Segmentation

By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Region

By  Product Type

· Active Safety Pen Needles

· Passive Safety Pen Needles

By Drug Type

· Insulin

· GLP-1

· Growth Hormone

· Others

By Disease Indication

· Diabetes

· Obesity

· Hormone Deficiency

· Others

By  Needle Size

· 4 mm

· 5 mm

· 6 mm

· 8 mm

· 12 mm

By  Distribution Channel

· Hospital Pharmacy

· Retail Pharmacy

· Online Pharmacy

By Region

· North America (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)

      - U.S.

      - Canada

· Europe (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)

      - U.K.

      - Germany

      - France

      - Italy

      - Spain

      - Scandinavia

      - Rest of Europe

· Asia Pacific (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)

      - China

      - Japan

      - India

      - Australia

      - Southeast Asia

      - Rest of Asia Pacific

· Latin America (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)

      - Brazil

      - Mexico

      - Rest of Latin America

· Middle East & Africa (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)

      - GCC

      - South Africa

      - Middle East & Africa

 

  • 2021-2034
  • 2025
  • 2021-2024
  • 200
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann